Clinical trial
Freedom Study: Myfortic in Kidney Transplant Patients
NCT00101738 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00101738 |
|---|---|
| Title | Freedom Study: Myfortic in Kidney Transplant Patients |
| Official title | Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic® in De Novo Kidney Tx Pts Using Simulect® and Neoral® With or Without Steroids |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Myfortic |
| Enrollment | 342 |
| Start date | Mar 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Jan 13, 2005 |
| Last update posted | Jan 31, 2011 |
| Countries | Argentina, Australia, Brazil, Canada, Germany, Italy, Malaysia, New Zealand, Singapore, Spain, Taiwan, United Kingdom and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: